The RBI has issued new guidelines allowing foreign-owned or controlled companies in India to buy and swap shares with local businesses, enhancing deal flexibility. This move clarifies and simplifies downstream investment procedures while restricting investments by Chinese subsidiaries in India using retained earnings.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected